Abstracts tagged "arthritis management"

Abstract Number: 2496 • 2015 ACR/ARHP Annual Meeting
Telerheumatology: A Technology Not Appropriate for All
Zsolt Kulcsar^1,2, Daniel Albert³, Ellyn Ercolano⁴ and John Mecchella⁵, ¹Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²Rheumatology/Leadership Preventive Medicine Residency, Dartmouth Hitchcock Medical Center, lebanon, NH, ³Medicine/Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, ⁴Telehealth, Dartmouth Hitchcock Center For Telehealth, Lebanon, NH, ⁵Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Title: Telerheumatology: A Technology Not Appropriate For AllBackground/Purpose: Access to Rheumatology care in New Hampshire (NH) and Vermont (VT) is limited, as a large proportion…
Abstract Number: 2524 • 2015 ACR/ARHP Annual Meeting
Longterm Follow-up of Children Born to Mothers with Chronic Arthritides and Exposed to Anti-TNF Alfa Agents during Pregancy and Breastfeeding: A Case-Control Study
Rossella Reggia¹, Laura Andreoli¹, Chiara Bazzani¹, Maria Grazia Lazzaroni¹, Giovanna Mazza¹, Michele Agosti¹, Roberto Gorla², Marco Taglietti², Andrea Lojacono³, Mario Motta⁴ and Angela Tincani⁵, ¹Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, ²Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, ³Obstetrics and Gynecology, Spedali Civili and University of Brescia, Brescia, Italy, ⁴Neonatal Intensive Care Unit, University and Spedali Civili of Brescia, Brescia, Italy, ⁵Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Brescia, Italy
Background/Purpose: Anti-TNFalfa agents have been used to control disease activity of patients with Chronic Arthritides (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis) during the wash-out period…
Abstract Number: 2565 • 2015 ACR/ARHP Annual Meeting
ACPA Specific IVIG Attenuate Collagen Induced Arthritis in Mice
Shaye Kivity¹, Nina Svetliscky¹, Qusim Odeh¹, Smadar Gertel¹, Howard Amital¹, Omer Gendelman¹, Iris Barshack², Alexander Volkov², Eran Bar-Meir³, Miri Blank¹ and Yehuda Shoenfeld⁴, ¹Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, ²Sheba Medical Center, Institute of Pathology, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, ³Plastic surgeon Poria Medical Center affiliated to Faculty of medicine in the Galilee Bar-Ilan university, Poria, Israel, ⁴Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel
Background/Purpose: Administration of intravenous-immunoglobulin (IVIg) is a recognized safe and efficient immunomodulatore therapy for many autoimmune diseases. Anti-idiotypic antibody binding to pathogenic autoantibodies was proposed…
Abstract Number: 2572 • 2015 ACR/ARHP Annual Meeting
Protective and Therapeutic Effects of Growth Hormone on Collagen-Induced Arthritis
Ricardo J. Villares¹, Gabriel Criado², Rosa P Gomariz³, Yasmina Juarranz³, Javier Leceta³, Graciela Cascio⁴, Jose L. Pablos⁵ and Mario Mellado⁶, ¹Immunology & Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain, ²Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, ³Cellular Biology, School of Biology. Universidad Complutense de Madrid, Madrid, Spain, ⁴Immunoloy & Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain, ⁵Instituto de Investigacion Hospital, Madrid, Spain, ⁶Immunology and Oncology, Centro Nacional de Biotecnología. CNIC, Madrid, Spain
Background/Purpose: Inflammatory (M1) macrophages and T helper 17 (TH17) cells are central to rheumatoid arthritis (RA) pathogenesis. Although the growth hormone [GH]/insulin-like growth factor 1…
Abstract Number: 2875 • 2015 ACR/ARHP Annual Meeting
Anti-TNF Therapy Is Not Associated with an Increase in Neoplasias in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry
Fabiola Atzeni¹, Antonio Carletto², Marco Sebastiani³, Valentina Panetta⁴, Fausto Salaffi⁵, Florenzo Iannone⁶, Elisa Gremese⁷, Marcello Govoni⁸, Antonio Marchesoni⁹, Roberto Gorla¹⁰, Roberta Ramonda¹¹, Pier Carlo Sarzi-Puttini¹², Gianfranco Ferraccioli⁷, Giovanni Lapadula¹³ and on behalf of GISEA group, ¹Rheumatology Unit, L. Sacco University Hospital of Milan, Milan, Italy, ²Rheumatology Unit, University of Verona, Verona, Italy, ³SC Reumatologia, Dipartimento di Medicine, Medicina d’Urgenza e Specialità Mediche, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy, ⁴L'altrastatistica -Consultancy & Training- Biostatistics office., Rome, Italy, ⁵Rheumatology Department, Polytechnic University of Marche, C. Urbani Hospital, Jesi,, Ancona, Italy, ⁶Interdisciplinary Department of Medicine (DIM), Rheumatology Unit, University of Bari, Bari, Italy, ⁷Division of Rheumatology, Institute of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, ⁸Department of Medical Sciences, UOC of Rheumatology, Azienda Ospedaliero-Universitaria S. Anna-Ferrara, University of Ferrara, Cona Ferrara, Italy, ⁹Rheumatology Unit, Orthopedic Institute G. Pini, Milano, Italy, ¹⁰Rheumatology and Immunology Unit, Spedali Civili di Brescia, Brescia, Italy, ¹¹Cattedra, Voc Rheumatology, University of Padua, Padova, Italy, ¹²Rheumatology Unit, L. Sacco University Hospital, Milan, Italy, ¹³Bari University, Rheumatology, Bari, Italy
Background/Purpose: The use of TNF inhibitors (TNFIs) has led to efficient control of the signs and symptoms of SpA and rheumatoid arthritis (RA), and significantly…
Abstract Number: 338 • 2013 ACR/ARHP Annual Meeting
Tailored Approach To Early Psoriatic Arthritis Patients: Ultrasonographic Predictors For Structural Joint Damage
Yasser El Miedany¹, Maha El Gaafary², Sally Youssef³ and Annie Nasr⁴, ¹Rheumatology, Medway Hospital, Gillingham, United Kingdom, ²Community, Environmental and Occupational Medicine, Ain Shams University, Cairo, Egypt, ³Rheumatology & Rehabilitation, Ain Shams University, Cairo, Egypt, ⁴Radiology, Ain Shams University, Cairo, Egypt
Background/Purpose: To evaluate the use of musculoskeletal US as a predictor for inflammatory structural progression in psoriatic patients Methods: Measures of association (OR) were tested,…
Abstract Number: 2873 • 2013 ACR/ARHP Annual Meeting
The Ion Channel TRPV2 Is New Suppressor of Arthritis Severity and Joint Damage
Teresina Laragione^1,2, Max Brenner^1,2, Christine Beeton³ and Percio Gulko^1,2, ¹Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, ²Molecular Medicine, Hosftra North Shore-LIJ School of Medicine, Manhasset, NY, ³Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX
Background/Purpose: Rheumatoid arthritis (RA) is a common and chronic disease associated with increased risk of developing disability. Disease remission is still rarely achieved and better…
Abstract Number: 2843 • 2013 ACR/ARHP Annual Meeting
An Education Needs Assessment: Findings From Surveys Of Patients and Caregivers
Elizabeth M. Badley^1,2, Monique A. Gignac^2,3,4, Lynn Moore⁵, Christina H. Chan⁶, Xingshan Cao⁷ and Julie Bowring⁸, ¹Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ²Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, ³Institute for Work and Health, Toronto, ON, Canada, ⁴Divison of Health Care & Outcomes Research, University Health Network, Toronto, ON, Canada, ⁵Programs and Services, The Arthritis Society, Toronto, ON, Canada, ⁶Division of Healthcare Outcomes and Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ⁷Divison of Health Care & Outcomes Research, Arthritis Community Research and Evaluation Unit , Toronto Western Research Institute, Toronto, ON, Canada, ⁸Arthritis Community Research and Evaluation Unit, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada
Background/Purpose: Getting trustworthy information to patients with arthritis is a challenge facing health professionals and organizations concerned with arthritis. This study examined the perceptions of…
Abstract Number: 2718 • 2013 ACR/ARHP Annual Meeting
Exploring E-Health Ethics and Multi-Morbidity: A Qualitative Study Of Patient and Clinician Experiences Using Digital Media For Health Purposes
Anne F. Townsend^1,2,3,4, Paul M Adam⁵, Linda C. Li^6,7, Jenny Leese¹, Michael McDonald⁸, Sheila Kerr⁹, Gordon Whitehead¹⁰ and Catherine L. Backman¹¹, ¹Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ²Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, ³Qualitative Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴University of British Columbia, Vancouver, BC, Canada, ⁵Rheumatology Liaison, Mary Pack Arthritis Centre, Vancouver, BC, Canada, ⁶Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ⁷Physical Therapy, Arthritis Centre of Canada, Richmond, BC, Canada, ⁸Maurice Young Centre for Applied Ethics, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, ⁹Arthritis Patient Advisory Board, Richmond, BC, Canada, ¹⁰Consumer Advisory Board, Vancouver, BC, Canada, ¹¹Arthritis Research Centre of Canada, Richmond, BC, Canada
Background/Purpose: E-Health can potentially transform and enhance health care delivery and empower patients. E-health includes a spectrum of digital health services and information communicated through…
Abstract Number: 2240 • 2013 ACR/ARHP Annual Meeting
Correlative Analysis Of Swollen Joints Between Clinical Examination and Musculoskeletal Ultrasound For Rheumatoid Arthritis
Kenta Misaki¹, Takashi Nakazawa², Shunichi Fujita¹, Hirotaka Yamada¹ and Toshihiko Yokota¹, ¹Rheumatology, Kurashiki Central Hospital, Kurashiki, Japan, ²Rheumatology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan
Background/Purpose: The disease activity score 28 (DAS28), clinical disease activity index (CDAI) and simplified disease activity index (SDAI) are all used in the clinical assessment…
Abstract Number: 2218 • 2013 ACR/ARHP Annual Meeting
Gingival Stem Cells Suppress Osteoclast Formation and Bone Erosion In CIA Through CD39 Signal
Song Guo Zheng¹, Jian Gu², Maogeng Chen¹ and Yi Shen³, ¹Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, ²Medcine, University of Southern California Keck School of Medicine, Los Angeles, CA, ³Medicine, Shanghai East Hospital at Tongji University, Shanghai, China
Background/Purpose: We recently have reported that human-derived gingival mesenchymal stem cells (GMSC) have strong capacity to suppress immune responses and T cell-mediated collagen-induced arthritis, however,…
Abstract Number: 2015 • 2013 ACR/ARHP Annual Meeting
Sarcoid Arthritis In World Trade Center Exposed New York City Firefighters Presenting As a Unique Clinical Subset
Konstantinos Loupasakis¹, Jessica Berman², Michelle S Glaser^3,4, Nadia Jaber⁴, Rachel Zeig-Owens^3,4, Mayris P Webber^4,5, Michael D Weiden^4,6, Anna Nolan^4,7, Kerry J Kelly⁴ and David J Prezant^4,8, ¹Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, ²Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, ³Medicine, Montefiore Medical Center, Bronx, NY, ⁴Bureau of Health Services Fire Department of New York, Brooklyn, NY, ⁵Medicine and Epideiology and Population Health, Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY, ⁶Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, ⁷Medicine, New York University School of Medicine, New York, NY, ⁸Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Sarcoidosis is a multisystem disease characterized by the formation of non-caseating granulomas with lungs being predominantly affected and the joints in up to 40%.…
Abstract Number: 1931 • 2013 ACR/ARHP Annual Meeting
Models Of Care For Arthritis: Drivers, Facilitators and Barriers To Their Development and Implementation
Aileen M. Davis¹, Cheryl Cott², Rose Wong³, Michel Landry⁴, Linda Li⁵, Allyson Jones⁶, Cy Frank⁷, Sydney C. Lineker⁸, Louise Bergeron⁹, Gillian A. Hawker¹⁰, Dianne P. Mosher¹¹, Vandana Ahluwalia¹², Michel Zummer¹³, Susan B. Jaglal¹⁴, Rhona McGlasson¹⁵, Richard Birtwhistle¹⁶, Sherry Bar¹⁷ and Elizabeth M. Badley¹⁸, ¹Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Ontario, ON, Canada, ²Divison of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ³Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ⁴Department of Community and Family Medicine, Physical Therapy Division, Duke University Medical Center, Durham, NC, ⁵Arthritis Centre of Canada and Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ⁶Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, ⁷Alberta Bone and Joint Institute and Department of Surgery, University of Calgary, Calgary, AB, Canada, ⁸The Arthritis Society, Toronto, ON, Canada, ⁹Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, ¹⁰Women's College Research Institute, University of Toronto, Toronto, ON, Canada, ¹¹Med, University of Calgary, Calgary, AB, Canada, ¹²Past President, Ontario Rheumatology Association, Brampton, ON, Canada, ¹³Rheumatology, Ch Maisonneuve-Rosemont, Montreal, QC, Canada, ¹⁴Department of Physical Therapy, Department of Physical Therapy, University of Toronto, Toronto, ON, Canada, ¹⁵Bone and Joint Canada, Toronto, ON, Canada, ¹⁶Centre for Studies in Primary Care and Family Medicine and Community Health and Epidemiology, Queen's University, Kingston, ON, Canada, ¹⁷British Columbia Ministry of Health Services, Victoria, BC, Canada, ¹⁸Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada
Background/Purpose: Management of arthritis is a growing concern given disease prevalence and limited health care resources. In the context of a larger project investigating innovative…
Abstract Number: 1586 • 2013 ACR/ARHP Annual Meeting
Defining Hand Arthritis In Systemic Lupus Erythematosus, From An Ultrasound, Magnetic Resonance Imaging and Antibody Status Perspective
Elisabeth M.A Ball¹, Arthur Grey², Ai Lyn Tan³, Eiji Fukuba⁴, Gunter Steiner⁵, Dennis McGonagle⁶, Aubrey Bell⁷ and Madeleine Rooney⁸, ¹Rheumatology, Queens' University/Musgrave Park Hospital, Belfast, United Kingdom, ²Rheumatology, Musgrave Park Hospital, Belfast, United Kingdom, ³Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ⁴Department of Radiology, Shimane University, Izuma, Japan, ⁵Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ⁶NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, ⁷Rheumatology Unit, Musgrave Park Hospital, Belfast, United Kingdom, ⁸Medicine, Queens University Belfast, Belfast, United Kingdom
Background/Purpose: Musculoskeletal involvement in systemic lupus erythematosus (SLE) is common but poorly characterised with only a few Magnetic Resonance Imaging (MRI) or ultrasound (US) studies…
Abstract Number: 1279 • 2013 ACR/ARHP Annual Meeting
Anti-IL-6 Receptor Antibody Is Effective In Arthritis Regardless Of Obesity In Mouse Model
Miho Suzuki, Hiroto Yoshida and Yoshihiro Matsumoto, Product Research Department, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan
Background/Purpose: Compared with non-obese patients, obese patients with rheumatoid arthritis (RA) reportedly experience worsening of symptoms [Arthritis Care Res (Hoboken). 2013; 65: 78-87] and do…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].